Femme et Homme
- | Pays :
- United States
- Italy
- Spain
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this clinical research study is to learn if belatacept (BMS-224818) is expected to show acceptable rates of acute rejection (AR) in steroid-free belatacept-based immunosuppressive regiments compared to a similar steroid-free tacrolimus regimen. The long-term safety and tolerability of belatacept based regimens following long-term administration in subjects who have received a kidney transplant
Critère d'inclusion
- Disorder Related to Renal Transplantation